Alzheimer’s disease and related dementias are devastating conditions for a person and their family and caregivers. The progressive course of dementia can threaten an individual’s autonomy, and families can be emotionally, physically, mentally, and financially strained. Often, a
Guiding an Improved Dementia Experience by Clearing the Path for Comprehensive, High-Quality Dementia Care
September 2021
- Blog
Medicare Coverage of Innovative Technologies (MCIT)
The Centers for Medicare & Medicaid Services (CMS) is committed to ensuring people on Medicare have quicker access to innovative medical technologies for life-threatening or irreversibly debilitating diseases – like cancer and heart disease. In January 2021, we published a final rule called The Medicare Coverage of Innovative Technology and Definition of ‘Reasonable and Necessary’ (MCIT/R&N). The rule would have granted expedited Medicare coverage for up to four years for any U.S. Food & Drug Administration (FDA)-designated breakthrough device once the device received or cleared market Read more about Medicare Coverage of Innovative Technologies (MCIT) - Blog
My First 100 Days and Where We Go From Here: A Strategic Vision for CMS
We’ve learned a lot during the COVID-19 pandemic on the ways access to comprehensive health care affects our lives and well-being. The availability of COVID-19 tests, vaccines, and treatments have saved millions of Americans from sickness and death ̶ because the federal government stepped up to make sure that every person who needs COVID-related care has access to the care they need. But the challenge of the past 19 months has also put an incredible strain on our country’s health care infrastructure and highlighted weaknesses and disparities that cry out for smart and innovative solutions. I Read more about My First 100 Days and Where We Go From Here: A Strategic Vision for CMS